Laser Microdissection for Species-Agnostic Single-Tissue Applications
March 31st, 2022
A protocol is described that uses laser microdissection to isolate individual nematode tissues for RNA-sequencing. The protocol does not require species-specific genetic toolkits, allowing gene expression profiles to be compared between different species at the level of single-tissue samples.
Overview
This study presents a technique combining laser capture microdissection with the CEL-Seq2 protocol for generating transcriptomic data from small individual tissue samples. The method facilitates detailed gene expression analysis in C. elegans and can be adapted for non-model species, bypassing the need for species-specific genetic tools.
Key Study Components
Research Area
- Molecular biology
- Gene expression profiling
- Transcriptomics
Background
- Traditional methods are often insufficient for studying specific tissues or species.
- This innovative approach allows for individual tissue analysis.
- Highlights the utility of laser microdissection in RNA-sequencing.
Methods Used
- Laser capture microdissection
- C. elegans genitalia (tail tips) from larval stages
- CEL-Seq2 RNA-sequencing technology
Main Results
- Successfully isolated and processed tail tips of both male and hermaphrodite C. elegans.
- Enabled evaluation of gene expression levels in specific tissues.
- Demonstrated adaptability of the method for various species.
Conclusions
- This study showcases a robust method for isolating and analyzing tissue-specific RNA.
- The findings enhance the understanding of gene expression without the need for extensive genetic tools.
Frequently Asked Questions
Executive Industry Relevance
Laser microdissection (LMD) combined with single-cell RNA-seq enables species-agnostic, high-specificity transcriptomic profiling of discrete tissues without requiring genetic modification or cell dissociation. This approach addresses a critical gap in early discovery by allowing functional genomics in non-model organisms and tissues where conventional toolkits are unavailable. The method enhances predictive confidence in target validation and supports cross-species comparative studies for portfolio expansion.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of gene expression in native tissue microenvironments without species-specific genetic tools.
- Supports functional target validation by preserving cell context and minimizing stress-induced artifacts.
- Facilitates mechanistic de-risking for homologous tissue structures across diverse species.
- Improves predictive confidence in early-stage target selection and triage.
Screening & Assay Development
- Prepares highly specific tissue samples for downstream RNA-seq workflows, increasing assay relevance.
- Enables quantitative, reproducible transcriptomic outputs from small tissue samples.
- Supports standardization of sample preparation for cross-condition and cross-species comparisons.
- Provides a platform for scalable, reusable tissue-specific transcriptomics in discovery pipelines.
Translational & Preclinical Research
- Aligns transcriptomic data with disease-relevant tissue states for translational biomarker exploration.
- Enables continuity from discovery through preclinical validation in both model and non-model organisms.
- Supports risk-adjusted advancement decisions by providing robust, context-specific gene expression data.
- Facilitates comparative studies of gene regulatory networks across species for translational insights.
Pipeline & Workflow Integration
LMD-based tissue isolation integrates at the interface of early discovery and lead identification, enabling direct transcriptomic analysis of intact tissues prior to preclinical model development.
- Discovery Biology: Supports hypothesis testing and pathway clarification in native tissue contexts.
- Screening: Delivers assay-ready, reproducible tissue samples for quantitative RNA-seq analysis.
- Analytics: Provides quantitative gene expression measurements and statistical power analysis for condition comparisons.
- Translational Research: Enables cross-species and developmental stage comparisons for biomarker alignment.
- Enterprise Reuse: Offers a broadly applicable, species-agnostic workflow for diverse R&D programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes tissue isolation and RNA-seq preparation for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust, context-specific data generation.
- Portfolio Impact: Supports risk-adjusted prioritization and expansion into non-model species and tissues.
Implementation Considerations
- Requires expertise in microdissection, microscopy, and RNA-seq library preparation.
- Needs access to LMD instrumentation and high-quality RNA-seq analytical infrastructure.
- Demands rigorous cross-team standardization for sample handling and data analysis.
- Adaptation across species may require optimization of tissue preparation and synchronization protocols.
- Sample size and tissue accessibility may limit throughput; power analysis is essential for study design.
Biopharma FAQs
Chapters in this video
0:05
Introduction
1:00
Removing Mothers and Larvae and Collecting Newly Hatched L1s
2:00
Collecting L4 Males and Hermaphrodites and Fixation
3:07
Laser Microdissection and Setting up the Microscope
4:27
Cutting
6:27
Results: Appearance of Caenorhabditis elegans L3 Hermaphrodites and Males, the Focal Plane for the PEN Membrane Slide for Laser Dissection, and Power Analysis Using PowsimR
8:14
Conclusion
